Table 1.
Patients characteristics
| Characteristics | Total cohort (%) | Radical prostatectomy (%) |
|---|---|---|
| Patients | 274 (100) | 90 (100) |
| Age (years) | 66.8 ± 8.1 | 60.9 ± 6.8 |
| PSA (ng/mL) | ||
| <10 | 179 (65.3) | 68 (75.6) |
| 10–20 | 66 (24.1) | 18 (20.0) |
| >20 | 29 (10.6) | 4 (4.4) |
| Gleason score | ||
| ≤6 | 137 (50.0) | 60 (66.7) |
| 7 | 108 (39.4) | 24 (26.7) |
| ≥8 | 29 (10,6) | 6 (6.6) |
| cT-category before mpMRI | ||
| ≤T2a | 239 (87.2) | 84 (93.3) |
| T2b–T2c | 30 (11.0) | 6 (6.7) |
| T3a | 5 (1.8) | 0 |
| T3b | 0 | 0 |
| T4 | 0 | 0 |
| Risk groups | ||
| Low | 95 (34.7) | 43 (47.8) |
| Intermediate | 127 (46.4) | 37 (41.1) |
| High | 52 (19.0) | 10 (11.1) |
| Positive prostate biopsies | ||
| <50 % | 158 (57.7) | 49 (54.4) |
| ≥50 % | 65 (23.7) | 16 (17.8) |
| (Non classified) | 51 (18.6) | 25 (27.8) |
mpMRI multiparametric magnetic resonance imaging, PSA prostate-specific antigen